// App-Quantinova.ai

11034 : EpCAM-independent isolation of EMT- circulating tumor cells in patients with primary breast cancer who receive primary systemic therapy.

Researchers

Presenter

  • Fanny Le Du

Principal Investigators

  • Takeo Fujii

  • Darren W. Davis

  • Mariana Chavez-Mac Gregor

  • Carlos Hernando Barcenas

  • James L. Murray

  • Vicente Valero

  • Debu Tripathy

  • James M. Reuben

  • Naoto T. Ueno

  • Weiguo Wu

  • Summer Jackson

Medical Centers

  • ApoCell, Inc., Houston, TX

  • Apocell Inc, Houston, TXThe University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Cadherin 1

  • Circulating tumor cells

  • Cluster of Differentiation 44

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved